461 related articles for article (PubMed ID: 19761409)
1. Determination of group a streptococcal anti-M type-specific antibody in sera of rheumatic fever patients after 45 years.
Bencivenga JF; Johnson DR; Kaplan EL
Clin Infect Dis; 2009 Oct; 49(8):1237-9. PubMed ID: 19761409
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
McNeil SA; Halperin SA; Langley JM; Smith B; Warren A; Sharratt GP; Baxendale DM; Reddish MA; Hu MC; Stroop SD; Linden J; Fries LF; Vink PE; Dale JB
Clin Infect Dis; 2005 Oct; 41(8):1114-22. PubMed ID: 16163629
[TBL] [Abstract][Full Text] [Related]
3. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
[TBL] [Abstract][Full Text] [Related]
4. Group A streptococcus epidemiology and vaccine implications.
Cohen-Poradosu R; Kasper DL
Clin Infect Dis; 2007 Oct; 45(7):863-5. PubMed ID: 17806050
[No Abstract] [Full Text] [Related]
5. Prospects for a group A streptococcal vaccine.
McMillan DJ; Chhatwal GS
Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
[TBL] [Abstract][Full Text] [Related]
6. Epitopes of group A streptococcal M protein shared with antigens of articular cartilage and synovium.
Baird RW; Bronze MS; Kraus W; Hill HR; Veasey LG; Dale JB
J Immunol; 1991 May; 146(9):3132-7. PubMed ID: 2016540
[TBL] [Abstract][Full Text] [Related]
7. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen.
Dinkla K; Rohde M; Jansen WT; Kaplan EL; Chhatwal GS; Talay SR
J Clin Invest; 2003 Jun; 111(12):1905-12. PubMed ID: 12813026
[TBL] [Abstract][Full Text] [Related]
8. Immunity to group a streptococcal M proteins: forging a single-edged sword.
Madoff LC
Clin Infect Dis; 2005 Oct; 41(8):1123-4. PubMed ID: 16163630
[No Abstract] [Full Text] [Related]
9. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to group A streptococci.
Martins TB; Augustine NH; Hill HR
J Immunol Methods; 2006 Oct; 316(1-2):97-106. PubMed ID: 17010371
[TBL] [Abstract][Full Text] [Related]
10. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease.
Thakur A; Singhal S; Prakash K
J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254
[TBL] [Abstract][Full Text] [Related]
11. Isolation ratio and T- serotyping of group A streptococci from pediatric upper respiratory tract infections in Turkey.
Topkaya AE; Yildirim T; Arsan S
Anadolu Kardiyol Derg; 2005 Dec; 5(4):302-4. PubMed ID: 16330397
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic reactions with group-specific antigens of group A Streptococcus in rheumatic fever].
Zborovskiĭ AB; Lempert BA; Belousov SD; Filimonova IuK
Sov Med; 1990; (1):3-6. PubMed ID: 1693448
[TBL] [Abstract][Full Text] [Related]
13. Antibody levels to the class I and II epitopes of the M protein and myosin are related to group A streptococcal exposure in endemic populations.
Brandt ER; Yarwood PJ; McMillan DJ; Vohra H; Currie B; Mammo L; Pruksakorn S; Saour J; Good MF
Int Immunol; 2001 Oct; 13(10):1335-43. PubMed ID: 11581178
[TBL] [Abstract][Full Text] [Related]
14. Immune response to superoxide dismutase in group A streptococcal infection.
McMillan DJ; Davies MR; Good MF; Sriprakash KS
FEMS Immunol Med Microbiol; 2004 Apr; 40(3):249-56. PubMed ID: 15039102
[TBL] [Abstract][Full Text] [Related]
15. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
[TBL] [Abstract][Full Text] [Related]
16. Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?
Smeesters PR; McMillan DJ; Sriprakash KS; Georgousakis MM
Expert Rev Vaccines; 2009 Dec; 8(12):1705-20. PubMed ID: 19905872
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
18. Host-pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development.
Areschoug T; Carlsson F; Stålhammar-Carlemalm M; Lindahl G
Vaccine; 2004 Dec; 22 Suppl 1():S9-S14. PubMed ID: 15576204
[TBL] [Abstract][Full Text] [Related]
19. [Indicators of streptococcal infection and HLA antigens in patients with rheumatism].
Goriaeva NIu
Ter Arkh; 1986; 58(7):60-2. PubMed ID: 3532403
[TBL] [Abstract][Full Text] [Related]
20. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.
Olive C; Hsien K; Horváth A; Clair T; Yarwood P; Toth I; Good MF
Vaccine; 2005 Mar; 23(17-18):2298-303. PubMed ID: 15755615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
